Symbols

TNF Pharmaceuticals Plunges 16.13% on Reverse Stock Split

Generated by AI AgentAinvest Pre-Market Radar

Friday, Aug 29, 2025 4:31 am ET1min read

Aime Summary

- TNF Pharmaceuticals' stock plunged 16.13% pre-market after announcing a 100:1 reverse stock split to meet Nasdaq listing requirements.

- The split, effective September 2, reduces shares from 178.6M to 1.786M to avoid delisting risks due to low stock prices.

- The board aims to boost share price by consolidating shares, addressing governance concerns amid the significant pre-market decline.

On August 29, 2025, TNF PharmaceuticalsTNFA-- experienced a significant drop of 16.13% in pre-market trading, marking a notable decline in its stock performance.

TNF Pharmaceuticals has announced a reverse stock split, which will reduce the number of outstanding shares from 178,615,658 to 1,786,157. This move is aimed at meeting Nasdaq listing requirements and improving the company's share price. The split will take effect on September 2, 2025, with a ratio of 1 post-split share for every 100 pre-split shares. This strategic decision by the board of directors is intended to address the risk of delisting from the Nasdaq due to a low stock price.

Ainvest Pre-Market Radar

Get the scoop on pre-market movers and shakers in the US stock market.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue